These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18684098)

  • 21. Community-wide epidemic of hepatitis A--Shelby County, Tennessee.
    Skinner JT
    J Tenn Med Assoc; 1995 Dec; 88(12):468-9. PubMed ID: 8531480
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive value of immunization records and risk factors for immunization failure in internationally adopted children.
    Verla-Tebit E; Zhu X; Holsinger E; Mandalakas AM
    Arch Pediatr Adolesc Med; 2009 May; 163(5):473-9. PubMed ID: 19414695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-based survey of travel patterns among Canadians visiting hepatitis A-endemic countries.
    De Serres G; Duval B; Shadmani R; Rouleau I; Ouakki M; Naus M; Ward B
    J Travel Med; 2007; 14(4):269-73. PubMed ID: 17617850
    [No Abstract]   [Full Text] [Related]  

  • 24. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination.
    Vogt TM; Wise ME; Bell BP; Finelli L
    J Infect Dis; 2008 May; 197(9):1282-8. PubMed ID: 18422440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal hepatitis A vaccination in the United States: a call for action.
    Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD
    Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity to hepatitis A and B in Indian and Chinese immigrants seen in a travel clinic in Massachusetts, United States.
    Arya SC; Agarwal N
    J Travel Med; 2007; 14(1):74; author reply 75. PubMed ID: 17241260
    [No Abstract]   [Full Text] [Related]  

  • 27. Knowledge and use of measures to reduce health risks by corporate expatriate employees in western Ghana.
    Arya SC; Agarwal N; Gupta S
    J Travel Med; 2009; 16(1):78; author reply 78. PubMed ID: 19192139
    [No Abstract]   [Full Text] [Related]  

  • 28. The changing epidemiology of hepatitis A in British Columbia: using health authority follow-up data to inform policy and practice.
    Pollock SL; Sheikholeslami A; Edgar B; David ST; Buxton JA
    Can Commun Dis Rep; 2006 Oct; 32(20):239-44. PubMed ID: 17076034
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis A in Poland in 2003].
    Magdzik W
    Przegl Epidemiol; 2005; 59(2):289-95. PubMed ID: 16190532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breaking the chain: universal childhood hepatitis A virus vaccination.
    Temte JL
    Am Fam Physician; 2006 Jun; 73(12):2127-8. PubMed ID: 16836030
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis A vaccination effectiveness during an outbreak in the Ukraine.
    Selnikova O; Moisseeva A; Zadorozhnaja V; Dokachenko A; Kachur N; Gavrik S
    Vaccine; 2008 Jun; 26(25):3135-7. PubMed ID: 18486997
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis A: the beginning of the end?
    Armstrong C; Smith L
    Am Fam Physician; 2006 Jun; 73(12):2102. PubMed ID: 16836028
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis A: matching preventive resources to needs.
    Campos-Outcalt D
    J Fam Pract; 2004 Apr; 53(4):292-5. PubMed ID: 15068774
    [No Abstract]   [Full Text] [Related]  

  • 34. The United States and Canada as a coupled epidemiological system: an example from hepatitis A.
    Amariei R; Willms AR; Bauch CT
    BMC Infect Dis; 2008 Feb; 8():23. PubMed ID: 18307785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiologic aspects of viral hepatitis A and vaccination].
    Magdzik W
    Przegl Epidemiol; 2004; 58 Suppl 1():51-9. PubMed ID: 15807158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing travel-related global epidemiology of hepatitis A.
    Steffen R
    Am J Med; 2005 Oct; 118 Suppl 10A():46S-49S. PubMed ID: 16271541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical inquiries: Who should get hepatitis A vaccination?
    Brown R; Cable K; Sams R
    J Fam Pract; 2005 Jul; 54(7):624-5; discussion 624. PubMed ID: 16009092
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prophylaxis for contacts of an index case of hepatitis A: immunoglobulins or vaccination?].
    Gendrel D; Launay O; Moulin F; Larnaudie S; Hau I; Laurent C; Dubos F; Laurichesse H
    Presse Med; 2007; 36(7-8):1072-7. PubMed ID: 17603920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fulminant hepatitis A: Disappearing, but not soon enough.
    Koff RS
    Hepatology; 2006 Dec; 44(6):1397-9. PubMed ID: 17133466
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis A. Another vaccine-preventable disease continues to emerge.
    Goldrick BA
    Am J Nurs; 2004 Mar; 104(3):27-8. PubMed ID: 15108565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.